| Identification of targetable ERBB2 aberrations in head and neck squamous cell carcinoma AC Birkeland, M Yanik, BN Tillman, MV Scott, SK Foltin, JE Mann, ... JAMA Otolaryngology–Head & Neck Surgery 142 (6), 559-567, 2016 | 44 | 2016 |
| Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low‐risk, nontraditional patients MA Gingerich, JD Smith, NL Michmerhuizen, M Ludwig, S Devenport, ... Head & neck 40 (5), 943-954, 2018 | 36 | 2018 |
| Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma ML Ludwig, AC Birkeland, R Hoesli, P Swiecicki, ME Spector, JC Brenner Cancer biology & medicine 13 (1), 87, 2016 | 35 | 2016 |
| The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines ML Ludwig, A Kulkarni, AC Birkeland, NL Michmerhuizen, SK Foltin, ... Oral oncology 87, 144-151, 2018 | 32 | 2018 |
| The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel JE Mann, A Kulkarni, AC Birkeland, J Kafelghazal, J Eisenberg, ... Head & neck 41 (9), 3114-3124, 2019 | 30 | 2019 |
| The potential for tumor suppressor gene therapy in head and neck cancer AC Birkeland, ML Ludwig, ME Spector, JC Brenner Discovery medicine 21 (113), 41, 2016 | 29 | 2016 |
| Surveilling the potential for precision medicine-driven PD-1/PD-L1-targeted therapy in HNSCC JE Mann, R Hoesli, NL Michmerhuizen, SN Devenport, ML Ludwig, ... Journal of Cancer 8 (3), 332, 2017 | 26 | 2017 |
| The tip of the iceberg: clinical implications of genomic sequencing projects in head and neck cancer AC Birkeland, ML Ludwig, TS Meraj, JC Brenner, ME Prince Cancers 7 (4), 2094-2109, 2015 | 20 | 2015 |
| Genomic sequencing and precision medicine in head and neck cancers RC Hoesli, ML Ludwig, NL Michmerhuizen, AJ Rosko, ME Spector, ... European Journal of Surgical Oncology (EJSO) 43 (5), 884-892, 2017 | 15 | 2017 |
| Nuclear localization signal sequence is required for VACM-1/CUL5-dependent regulation of cellular growth AN Willis, SEB Dean, JA Habbouche, BT Kempers, ML Ludwig, AD Sayfie, ... Cell and tissue research 368, 105-114, 2017 | 14 | 2017 |
| Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene ME Heft Neal, AC Birkeland, AD Bhangale, J Zhai, A Kulkarni, SK Foltin, ... BMC cancer 21 (1), 636, 2021 | 11 | 2021 |
| Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana LE Merz, O Afriyie, E Jiagge, E Adjei, SK Foltin, ML Ludwig, JB McHugh, ... Health Science Reports 2 (2), e108, 2019 | 11 | 2019 |
| CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies JH Hwang, R Arafeh, JH Seo, SC Baca, M Ludwig, TE Arnoff, L Sawyer, ... Elife 11, e73223, 2022 | 10 | 2022 |
| Genome editing and engineering: from TALENs, ZFNs and CRISPRs to molecular surgery GM Church Cambridge University Press, 2018 | 9 | 2018 |
| Emerging role of extracellular vesicles in prostate cancer M Ludwig, R Rajvansh, JM Drake Endocrinology 162 (9), bqab139, 2021 | 6 | 2021 |
| Microbe-mediated activation of toll-like receptor 2 drives PDL1 expression in HNSCC JE Mann, ML Ludwig, A Kulkarni, EB Scheftz, IR Murray, J Zhai, ... Cancers 13 (19), 4782, 2021 | 5 | 2021 |
| Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma NL Michmerhuizen, ML Ludwig, AC Birkeland, S Nimmagadda, J Zhai, ... Head & neck 44 (5), 1192-1205, 2022 | 4 | 2022 |
| Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16‐positive oropharynx cancer JD Smith, ML Ludwig, AD Bhangale, C Brummel, PL Swiecicki, ... Head & Neck 45 (5), 1281-1287, 2023 | 3 | 2023 |
| 15 Generation and Utilization of CRISPR/Cas9 Screening Libraries in Mammalian Cells ML Ludwig, NM Michmerhuizen, RC Hoesli, JE Mann, SN Devenport, ... Genome editing and engineering: From TALENs, ZFNs and CRISPRs to molecular …, 2018 | 2 | 2018 |
| ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems HE Bergom, A Shabaneh, A Day, A Ali, E Boytim, S Tape, JR Lozada, ... Communications biology 6 (1), 417, 2023 | 1 | 2023 |
